BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11369819)

  • 1. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits.
    Vázquez-Pérez S; Aragoncillo P; de Las Heras N; Navarro-Cid J; Cediel E; Sanz-Rosa D; Ruilope LM; Díaz C; Hernández G; Lahera V; Cachofeiro V
    Nephrol Dial Transplant; 2001; 16 Suppl 1():40-4. PubMed ID: 11369819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits.
    Maeso R; Aragoncillo P; Navarro-Cid J; Ruilope LM; Diaz C; Hernández G; Lahera V; Cachofeiro V
    Gen Pharmacol; 2000 Apr; 34(4):263-72. PubMed ID: 11282220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
    Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
    Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits.
    Aragoncillo P; Maeso R; Vázquez-Pérez S; Navarro-Cid J; Ruilope LM; Díaz C; Hernández G; Lahera V; Cachofeiro V
    Virchows Arch; 2000 Nov; 437(5):545-54. PubMed ID: 11147177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits.
    de las Heras N; Cediel E; Oubiña MP; Aragoncillo P; Sanz-Rosa D; Lahera V; Cachofeiro V
    Clin Sci (Lond); 2003 Apr; 104(4):357-65. PubMed ID: 12653677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease.
    Alnaeb ME; Youssef F; Mikhailidis DP; Hamilton G
    Angiology; 2006; 57(1):65-71. PubMed ID: 16444458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions.
    Pretnar-Oblak J; Sabovic M; Sebestjen M; Pogacnik T; Zaletel M
    Stroke; 2006 Oct; 37(10):2540-5. PubMed ID: 16931784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve.
    Rajamannan NM; Subramaniam M; Stock SR; Stone NJ; Springett M; Ignatiev KI; McConnell JP; Singh RJ; Bonow RO; Spelsberg TC
    Heart; 2005 Jun; 91(6):806-10. PubMed ID: 15894785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women.
    Marchesi S; Lupattelli G; Siepi D; Schillaci G; Vaudo G; Roscini AR; Sinzinger H; Mannarino E
    J Cardiovasc Pharmacol; 2000 Nov; 36(5):617-21. PubMed ID: 11065222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effect of atorvastatin in hypercholesterolaemic renal-transplant patients unresponsive to other statins.
    Romero R; Calviño J; Rodriguez J; Sánchez-Guisande D
    Nephrol Dial Transplant; 2000 Sep; 15(9):1446-9. PubMed ID: 10978406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits.
    Aydin S; Uzun H; Sozer V; Altug T
    Pharmacol Res; 2009 Apr; 59(4):242-7. PubMed ID: 19429465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of statin therapy on endothelial function in hypercholesterolemic rabbits by automatic measurement of arterial wall movement using ultrasound images.
    Rahmani-Cherati T; Mokhtari-Dizaji M; Vajhi A; Rostami A
    Ultrasound Med Biol; 2014 Oct; 40(10):2415-24. PubMed ID: 25018028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
    Vlachopoulos C; Aznaouridis K; Dagre A; Vasiliadou C; Masoura C; Stefanadi E; Skoumas J; Pitsavos C; Stefanadis C
    Eur Heart J; 2007 Sep; 28(17):2102-9. PubMed ID: 17597050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
    Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
    J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of high doses of atorvastatin on the endothelial function of the coronary arteries].
    Simaitis A; Laucevicius A
    Medicina (Kaunas); 2003; 39(1):21-9. PubMed ID: 12576762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.
    Nawawi H; Osman NS; Annuar R; Khalid BA; Yusoff K
    Atherosclerosis; 2003 Aug; 169(2):283-91. PubMed ID: 12921980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
    Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
    Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
    Alber HF; Frick M; Süssenbacher A; Dörler J; Dichtl W; Stocker EM; Pachinger O; Weidinger F
    Wien Med Wochenschr; 2007 Feb; 157(3-4):73-8. PubMed ID: 17340064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.
    Tan KC; Chow WS; Tam SC; Ai VH; Lam CH; Lam KS
    J Clin Endocrinol Metab; 2002 Feb; 87(2):563-8. PubMed ID: 11836286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.